Second-line treatment options for patients with metastatic pancreatic ductal adenocarcinoma: A systematic literature review
Cancer Treatment Reviews · 2023-02 · 113 · 102502
DOI: 10.1016/j.ctrv.2022.102502 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Cancer Treatment Reviews, 2023-02. Verfasst von Farshid Dayyani und 3 weiteren Autor:innen. Beteiligte Einrichtung: University of California Irvine, Orange, CA, USA. Electronic address: fdayyani@hs.uci.edu. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Adenocarcinoma, Carcinoma, Pancreatic Ductal. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ipsen Biopharmaceuticals Inc.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of California Irvine, Orange, CA, USA. Electronic address: fdayyani@hs.uci.edu.
- Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
- Ipsen, Cambridge, MA, USA.
- Ronald Reagan UCLA Medical Center, Los Angeles, CA, USA.
Förderung
- Ipsen Biopharmaceuticals Inc
Zitieren
APA
Dayyani, F., Macarulla, T., Johnson, A., & Wainberg, Z. A. (2023). Second-line treatment options for patients with metastatic pancreatic ductal adenocarcinoma: A systematic literature review. Cancer Treatment Reviews, 113, 102502. https://doi.org/10.1016/j.ctrv.2022.102502
Vancouver
Dayyani F, Macarulla T, Johnson A, Wainberg ZA. Second-line treatment options for patients with metastatic pancreatic ductal adenocarcinoma: A systematic literature review. Cancer Treatment Reviews. 2023;113:102502. doi:10.1016/j.ctrv.2022.102502
BibTeX
@article{Dayyani2023,
author = {Dayyani, Farshid and Macarulla, Teresa and Johnson, Andrew and Wainberg, Zev A},
title = {Second-line treatment options for patients with metastatic pancreatic ductal adenocarcinoma: A systematic literature review},
journal = {Cancer Treatment Reviews},
year = {2023},
volume = {113},
pages = {102502},
doi = {10.1016/j.ctrv.2022.102502}
}
EUVIMED